Skip to main content
. 2017 Aug 2;8(40):68599–68613. doi: 10.18632/oncotarget.19803

Table 1. Patient characteristics.

TNM 1 short term survivors trainingset Group A (n=10) TNM 1 long term survivors trainingset Group B (n=10) TNM 1validatingset Group C (n=17) TNM 1short follow upsetGroup D (n=12) TNM 2 short term survivors training set Group E (n=5) TNM 2 long term survivors training set Group F (n=5) TNM 2validatingset Group G (n=7) TNM 2 short follow upset Group H (n=5)
Gender
 Male n(%) 6 (60) 5 (50) 8 (47) 1 (8) 2 (40) 2 (40) 4 (57) 2 (40)
 Female n(%) 4 (40) 5 (50) 9 (53) 11 (92) 3 (60) 3 (60) 3 (43) 3 (60)
Age
 Median years at surgery (range) 65.5 (46-74) 64 (54-75) 64 (28-80) 64.5 (41-84) 67 (52-70) 80 (48-88) 65 (56-76) 61 (49-68)
 Median months survival (range) 34.6 (10.4-52.9) 73.9 (62.9-99.3) 59.6 (11.7-99.2) 24.3 (0.7-42.2) 12.2 (8.1-23.3) 36.9 (30.6-73.5) 29.6 (23.3-98.2) 19.1 (1.3-23.5)
TNM
 Stage 1A n(%) 4 (40) 5 (50) 5 (29) 3 (25) 0 (0) 0 (0) 0 (0) 0 (0)
 Stage 1B n(%) 6 (60) 5 (50) 12 (71) 9 (75) 0 (0) 0 (0) 0 (0) 0 (0)
 Stage 2A n(%) 0 (0) 0 (0) 0 (0) 0 (0) 2 (40) 2 (40) 1 (16) 3 (60)
 Stage 2B n(%) 0 (0) 0 (0) 0 (0) 0 (0) 3 (60) 3 (60) 6 (84) 2 (40)
 N0 n(%) 10 (100) 10 (100) 17 (100) 12 (100) 2 (40) 3 (60) 4 (57) 2 (40)
 N1 n(%) 0 (0) 0 (0) 0 (0) 0 (0) 3 (60) 2 (40) 3 (43) 3 (60)
Tobacco pack-years
 None n(%) 0 (0) 0 (0) 3 (17.6) 1 (8.3) 4 (80) 1 (20) 1 (15) 2 (40)
 <30 n(%) 1 (10) 2 (20) 5 (29.5) 3 (25) 0 (0) 2 (40) 4 (55) 1 (20)
 31-49 n(%) 3 (30) 5 (50) 3 (17.6) 0 (0) 0 (0) 2 (40) 1 (15) 1 (20)
 >50 n(%) 6 (60) 3 (30) 6 (35.3) 8 (66.6) 1 (20) 0 (0) 1 (15) 1 (20)
EGFR status
 Mutated EGFR mutated/tested (% mutated) 0/5 (0) 0/2 (0) 2/8 (25) 0/10 (0) 1/4 (25) 0/2 (0) 0/3 (0) 0/3 (0)
 Amplified EGFR amplified/tested (% amplified) 1/5(20) 0/2 (0) 2/8 (25) 3/9 (33) 3/4 (75) 1/2 (50) 0/2 (0) 1/3 (30)
 Mutated or amplified EGFR positive/tested (% positive) 1/5 (20) 0/2 (0) 3/8 (37.5) 3/9 (33) 3/4 (75) 1/2 (50) 0/3 (0) 1/3 (30)
Disease status
 Locally recurrent (yes/no/unknown) (8/1/1) (0/10/0) (7/10/0) (0/12/0) (4/1/0) (2/3/0) (0/7/0) (0/5/0)
 Metastatic (yes/no/unknown) (8/1/1) (0/10/0) (4/11/2) (0/12/0) (5/0/0) (2/3/0) (1/6/0) (0/5/0)
 Adjuvant therapy n(%) 0 (0) 0 (0) 2 (12) 2 (17) 2 (40) 1 (20) 4 (57) 3 (60)
Cause of death
 Alive n(%) 0 (0) 10 (100) 11 (65) 12 (100) 0 (0) 5 (100)) 6 (85) 5 (100)
 Deceased of Lung cancer n(%) 10 (100) 0 (0) 6 (35) 0 (0) 5 (100) 0 (0) 1 (15) 0 (0)